Pharmacologic management of nonpain symptoms in surgical patients

Surgical Oncology Clinics of North America

Volumn 10, Issue 1, 2001, Pages 89-107

  Bruera, E ^a   Beattie Palmer, L N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CISAPRIDE; CORTICOSTEROID; GESTAGEN; HALOPERIDOL; LAXATIVE; METOCLOPRAMIDE; MIDAZOLAM; NEUROLEPTIC AGENT; OPIATE ANTAGONIST; OPIATE DERIVATIVE; PROKINETIC AGENT;

ANOREXIA; ANXIETY NEUROSIS; ASTHENIA; CACHEXIA; CONSTIPATION; DELIRIUM; DEPRESSION; DYSPNEA; FAMILY COUNSELING; HUMAN; INTERPERSONAL COMMUNICATION; NAUSEA; PAIN; PALLIATIVE THERAPY; PATIENT CARE; REVIEW; SURGICAL PATIENT; SYMPTOMATOLOGY;

EID: 0035132290     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30087-5     Document Type: Review

References (59)

1. Anxiety, depression, asthenia and personality disorders
2. Cisapride: A gastrointestinal prokinetic drug
3. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomized placebo-controlled trial
4. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer
5. Psychiatric aspects of palliative care
6. Methylphenidate associated with narcotics for the treatment of cancer pain
7. Association between involuntary muscle tension (IMF) and asthenia (AST), nutritional status (NS), lean body mass (LBM), psychometric assessment and tumor mass (TM) in patients (PTS) with advanced breast cancer
8. Double blind evaluation of mazindol in enhancing the comfort of terminally ill cancer patients
9. Chronic nausea and anorexia in patients with advanced cancer: A possible role for autonomic dysfunction
10. Study of cardiovascular autonomic insufficiency in advanced cancer patients
11. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients
12. Effectiveness of megestrol acetate in patients with advanced cancer: A randomized, double blind, cross over study
13. Asthenia in patients with advanced cancer
14. Subcutaneous morphine for dyspnea in cancer patients
15. Comparison of the efficacy, safety and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer
16. Cognitive failure in patients with terminal cancer: A prospective study
17. The uses of psychotropics in symptom management in advanced cancer
18. Management of specific symptom complexes in patients receiving palliative care
19. Dyspnea in patients with advanced cancer
20. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study
21. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: The use of the N of 1 randomized controlled trial
22. Chronic nausea in advanced cancer patients: A retrospective assessment of a metoclopramide-based antiemetic regimen
23. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: A retrospective review
24. Continuous intravenous infusion of morphine for severe dyspnea
25. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to brochodilator therapy
26. Reduction in constipation and laxative requirements following opioid rotation to methadone: A report of four cases
27. The role of nebulised drugs in palliating respiratory symptoms of malignant disease
28. Quality-of-life benefit in chemotherapy patients treated with epoetin-alpha is independent of disease response or tumor type: Results from a prospective community oncology study
29. Assessment and management of opioid-induced constipation
30. The prevalence of psychiatric disorders among cancer patients
31. Dextroamphetamine with morphine for the treatment of postoperative pain
32. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
33. Blood transfusion and its benefits in palliative care
34. Fatigue syndrome due to localized radiation
35. Depression and chronic fatigue in cancer patients
36. A preliminary study of clinical predictors for lack of energy in patients (pts) with advanced cancer
37. A critical appraisal of the research literature investigating fatigue in the individual with cancer
38. The Edmonton functional assessment tool: Preliminary development and evaluation for use in palliative care
39. Cancer rehabilitation: Assessment of need, development and evaluation of a care model
40. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease
41. Skeletal muscle function in malnutrition
42. The central and peripheral influences of opioids on gastrointestinal propulsion
43. Constipation in advanced cancer patients
44. The role of octreotide in palliative care
45. Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit
46. Asthenia-cachexia
47. Chronic nausea
48. The frequency and clinical course of cognitive impairment in patients with terminal cancer
49. Asthenia, weakness and fatigue
50. Methylprednisolone as palliative therapy for female terminal cancer patients
51. Constipation in the cancer patient: Causes and management
52. Cancer-related fatigue: Guidelines for evaluation and management
53. CNS adverse effects of opioids in cancer patients: Guidelines for treatment
54. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients
55. The plain abdominal radiograph in the assessment of constipation
56. Fatigue in advanced cancer: A prospective controlled cross-sectional study
57. Asthenia in cancer
58. The use of laxative at a palliative care centre